{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:06:24Z","timestamp":1790093184923,"version":"4.0.1"},"reference-count":169,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R61HL156158"],"award-info":[{"award-number":["R61HL156158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NHLBI"],"award-info":[{"award-number":["NHLBI"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1080\/13543776.2022.1994945","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T19:28:34Z","timestamp":1634498914000},"page":"115-130","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property"],"prefix":"10.1080","volume":"32","author":[{"given":"Piyusha P.","family":"Pagare","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Rastegar","sequence":"additional","affiliation":[{"name":"The Institute for Structural Biology, Drug Discovery, and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osheiza","family":"Abdulmalik","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelsattar M.","family":"Omar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Alsulaymanyah, Jeddah, Saudi Arabia"},{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fleischman","sequence":"additional","affiliation":[{"name":"Illexcor Therapeutics, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Safo","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond VA, USA"},{"name":"The Institute for Structural Biology, Drug Discovery, and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2016.10.002"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2017.12.003"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24235"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61229-X"},{"key":"cit0006","unstructured":"Data & Statistics on Sickle Cell Disease. [cited 2021 Apr 29]. Available from: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/180326a0"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3002(58)90516-X"},{"key":"cit0009","volume-title":"Hemoglobin\u2013molecular, genetic, and clinical aspect","author":"Bunn HF","year":"1986"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2016.04.003"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1080\/10739680490278312"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106294"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74604"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13667-8"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(83)80109-0"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)86871-0"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1038\/283832a0"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.3109\/00313021003631197"},{"key":"cit0019","volume-title":"Sickle cell disease","author":"Sedrak A","year":"2018"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.07.001"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2011.02.013"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-41769-7_14"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1110\/ps.48301"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1038\/237495a0"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.27.1.1"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(84)90472-8"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(79)90277-8"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.4.1418"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1021\/bi00046a007"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)33681-5"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1021\/bi048531d"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1021\/bi7023699"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0674"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1038\/375084a0"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(92)90902-V"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1021\/bi047813a"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)41919-9"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444908037256"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3180653c0d"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.1768"},{"issue":"2","key":"cit0043","first-page":"H602","volume":"271","author":"Kunert MP","year":"1996","journal-title":"Am J Physiol"},{"issue":"4","key":"cit0044","first-page":"H1450","volume":"265","author":"Khandelwal SR","year":"1993","journal-title":"Am J Physiol"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0075-9_27"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1667\/RR0962.1"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1021\/jm0498001"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798318009919"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2018.04.015"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444911036353"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77171-2"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01287"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200890165"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.6.2209"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.6.1334.1334"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)75254-5"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05332.x"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00553"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00491"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14214"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018GS110347"},{"issue":"1539","key":"cit0063","first-page":"21","volume":"60","year":"2018","journal-title":"Med Lett Drugs Ther"},{"issue":"8","key":"cit0064","first-page":"620","volume":"42","author":"Kaufman MB","year":"2017","journal-title":"P T"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2329"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"cit0067","unstructured":"FDA approves hydroxyurea for treatment of pediatric patients with sickle cell anemia. [cited 2018 Mar 10]. Available from: https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm590096.htm"},{"issue":"3","key":"cit0068","first-page":"74","volume":"19","author":"Goldberg MA","year":"1992","journal-title":"Semin Oncol"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0708272"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00035-15"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.10.2555.2555"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.3233\/CH-170340"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14264"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.11.001"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137121"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08520.x"},{"issue":"3","key":"cit0077","first-page":"179","volume":"74","author":"Herrick JB","year":"2001","journal-title":"Yale J Biol Med"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1126\/science.110.2865.543"},{"issue":"5","key":"cit0079","first-page":"334","volume":"40","author":"Pauling L","year":"1964","journal-title":"Bull N Y Acad Med"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1038\/219131a0"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(77)90256-X"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1038\/199633a0"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.2.324"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1021\/bi00587a001"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.12.5499"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)85812-X"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1021\/jm020361k"},{"issue":"3","key":"cit0088","first-page":"559","volume":"26","author":"Garel MC","year":"1984","journal-title":"Mol Pharmacol"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(86)90105-6"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)66928-5"},{"key":"cit0091","unstructured":"Abraham DJ Sickle cell anemia treatment and compound. US4482571A. 1984."},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1021\/jm00368a001"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1038\/275238a0"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1021\/bi00535a046"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1021\/bi00618a020"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1016\/0885-4505(87)90077-6"},{"issue":"3","key":"cit0097","first-page":"589","volume":"12","author":"Patwa DC","year":"1987","journal-title":"Blood Cells"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1021\/jm00378a005"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197110282851803"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)34961-3"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V48.2.273.273"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01106.x"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02508-3"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013373778"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1126\/science.7256275"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1021\/bi00555a014"},{"key":"cit0107","first-page":"1","author":"Safo MK","year":"2021","journal-title":"Burger\u2019s Med Chem Drug Discovery"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1021\/jm00358a017"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1984.tb10775.x"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1021\/ja00265a036"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1987.tb02278.x"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1042\/bj2390387"},{"key":"cit0113","doi-asserted-by":"crossref","unstructured":"Kneen G Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation. US4535183A. 1985.","DOI":"10.1016\/0883-2897(86)90158-3"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1744.x"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90941-4"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02672.x"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb04465.x"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04892.x"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1039\/c0gc00401d"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1021\/cr300182k"},{"key":"cit0121","unstructured":"Safo MK Anti-sickling agents. US7119208B2. 2006."},{"key":"cit0122","unstructured":"Safo M Anti-sickling agents. US20040157801A1. 2004."},{"key":"cit0123","unstructured":"Testing status of 5-(Hydroxymethyl)-2-furfural M950006. [cited 2021 Jun 9]. Available from: https:\/\/ntp.niehs.nih.gov\/whatwestudy\/testpgm\/status\/ts-m950006.html?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=ts-m950006"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.3210.3210"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2018.1471983"},{"key":"cit0126","unstructured":"Safo MK Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives. US10875834B2. 2020."},{"key":"cit0127","unstructured":"Safo MK Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-hmf) and its derivatives. WO2018018035A1. 2018."},{"key":"cit0128","unstructured":"Omar AME Metabolically stable 5-HMF derivatives for the treatment of hypoxia. US10836729B1. 2020."},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(77)80093-4"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.1.183.183"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311562200"},{"key":"cit0132","unstructured":"Safo M Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease. US10858331B1. 2020."},{"key":"cit0133","unstructured":"Safo M Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease. US20210053931A1. 2021."},{"key":"cit0134","unstructured":"Pagare P Rational design of allosteric modulators of hemoglobin as dual acting antisickling agents. Theses and Dissertations 2018."},{"key":"cit0135","doi-asserted-by":"crossref","unstructured":"Safo MK Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease. US20210002225A1. 2021.","DOI":"10.1002\/0471266949.bmc270"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb04160.x"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13896"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.02016.x"},{"key":"cit0139","unstructured":"Li Z Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin. US9802900B2. 2017."},{"key":"cit0140","unstructured":"Metcalf BW Compounds and uses thereof for the modulation of hemoglobin. US10017491B2. 2018."},{"key":"cit0141","unstructured":"Metcalf , BW 2018 Compounds and uses thereof for the modulation of hemoglobin US9957250B2."},{"key":"cit0142","unstructured":"Xu Q Compounds and uses thereof for the modulation of hemoglobin. US10450269B1. 2019."},{"key":"cit0143","unstructured":"Li Z Compounds and uses thereof for the modulation of hemoglobin. US10266551B2. 2019."},{"key":"cit0144","unstructured":"Metcalf B Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation. US10806733B2. 2020."},{"key":"cit0145","unstructured":"Xu Q Compounds and uses thereof for the modulation of hemoglobin. US10858317B2. 2020."},{"key":"cit0146","unstructured":"Metcalf , B 2021 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation. US10822326B2"},{"key":"cit0147","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.1370.1370"},{"key":"cit0148","unstructured":"Sinha U Compositions and methods for the modulation of hemoglobin (s). WO2014150256A1. 2014."},{"key":"cit0149","unstructured":"Metcalf B Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation. US9018210B2. 2015."},{"key":"cit0150","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.217.217"},{"key":"cit0151","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.316.316"},{"key":"cit0152","unstructured":"Ramos EL Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde. WO2017096230A1. 2017."},{"key":"cit0153","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868893"},{"key":"cit0154","unstructured":"FDA approves voxelotor for sickle cell disease. [cited 2021 Apr 12]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-voxelotor-sickle-cell-disease"},{"key":"cit0155","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106161"},{"key":"cit0156","unstructured":"Metcalf BW 1:1 adducts of sickle hemoglobin. US9248199B2. 2016."},{"key":"cit0157","unstructured":"Metcalf BW Modulators of hemoglobin. US11014884B2. 2021."},{"key":"cit0158","unstructured":"Jin B Hemoglobin modifier compounds and uses thereof. US10787430B2. 2020."},{"key":"cit0159","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00108"},{"key":"cit0160","doi-asserted-by":"publisher","DOI":"10.1021\/cb500230b"},{"key":"cit0161","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111508"},{"key":"cit0162","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00291J"},{"key":"cit0163","doi-asserted-by":"publisher","DOI":"10.1039\/C5OB00367A"},{"key":"cit0164","unstructured":"Abraham DJ Method of treating sickle cell anemia. US4887995A. 1989."},{"key":"cit0165","unstructured":"Safo MK Azolylacryloyl derivatives as therapeutic agents for sickle cell disease. US10344001B2. 2019."},{"key":"cit0166","unstructured":"Zapol WM Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin. US10758569B2. 2020."},{"key":"cit0167","unstructured":"Gopalsamy A Chemical compounds. US11014908B2. 2021."},{"key":"cit0168","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01518"},{"key":"cit0169","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.2172.2172"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2022.1994945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T12:21:57Z","timestamp":1645705317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2022.1994945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"alternative-id":["10.1080\/13543776.2022.1994945"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2022.1994945","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}